istarioncology.com
Contate-nos
Sobre companhia
Istari Oncology is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The Company was founded in 2016 by Darell Bigner, MD, and Matthias Gromeier, MD to continue research and clinical development of technology discovered at Duke University.
US
Desconhecido
Empresa não verificada
Transparência de negócios
- Não verificou as informações da empresa
- Peça avaliações aos seus clientes
- Não respondeu a comentários negativos